Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – 9,10-seco- cyclopentanohydrophenanthrene ring system doai
Patent
1997-05-27
2000-06-13
O'Sullivan, Peter
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
9,10-seco- cyclopentanohydrophenanthrene ring system doai
514861, 514863, 552653, 556443, A61K 3159
Patent
active
060750154
ABSTRACT:
Vitamin D.sub.3 analogues of the formula (I): ##STR1## wherein R.sub.1 is hydrogen or hydroxy, R.sub.2 is (C.sub.1 -C.sub.3)alkyl, hydroxy(C.sub.1 -C.sub.3)alkyl, (C.sub.1 -C.sub.2)alkoxymethyl, (C.sub.2 -C.sub.3)alkenyl, or (C.sub.2 -C.sub.3)alkynyl, R.sub.3 is a branched or unbranched, saturated or unsaturated aliphatic 3- to 5- membered hydrocarbon or oxahydrocarbon biradical, having at least 3 atoms in the main chain and being optionally substituted with one or more substituents selected from epoxy, fluoro and hydroxy, R.sub.4 is sec. or tert. (C.sub.3 -C.sub.6)alkyl or (C.sub.3 -C.sub.6)cycloalkyl, A and B are each individually hydrogen or methyl, or A and B together from methylene. The compounds of the present invention exhibit pharmacotherapeutic activities, including in particular, the treatment of osteoporosis, renal osteodystrophy, osteomalacia, skin disorders such as psoriasis and other hyperproliferative skin diseases, eczema and dermatitis, nmyopathy, leukemia, breast and colon cancer, osteosarcomas, squamous cell carcinomas, melanoma, certain immunological disorders, and transplant rejections. Several methods of synthesis, including reaction of an ester compound of general formula (IX) with an inorganometallic compound of formula (III) followed by deprotection or, alternatively, first finalization of the C.sub.17 -side chain are also disclosed.
REFERENCES:
patent: 4866048 (1989-09-01), Calverley et al.
patent: 5190935 (1993-03-01), Bendeup et al.
patent: 5206229 (1993-04-01), Calverley et al.
patent: 5292728 (1994-03-01), Neef et al.
patent: 5321018 (1994-06-01), DeLuca
patent: 5342975 (1994-08-01), DeLuca et al.
patent: 5374629 (1994-12-01), Calverley et al.
patent: 5378695 (1995-01-01), Calverley et al.
patent: 5401731 (1995-03-01), Caluerley et al.
patent: 5401732 (1995-03-01), Calverley et al.
patent: 5430196 (1995-07-01), DeLuca et al.
patent: 5447924 (1995-09-01), Bretting
patent: 5459136 (1995-10-01), Deluca et al.
Calverley, et al, "Vitamin D" in Amtitumor Steroids by R. T. Blickenstaff, pp 193-270 (1992).
J. Chem Soc. Perkin Trens I, de Costa, et al, (1985) pp 1331-1336.
Napoli, et al, Biochemistry; 19 (1980) pp. 2515-2521.
Sestelo, et al. J. Org. Chem, 58 (1993) pp 118-123.
Sestelo et al, J. Org. Chem., 1993, 58, pp. 118-123, "Ultra-Sonically Induced Conjugate Addition of Iodides to . . . ".
Journal of Organic Chemistry, vol. 58, No. 1, Jan. 1, 1993, Easton, U.S., pp. 118-123, J.P. Sestelo et al., "Ultrasonically induced conjugate addition of iodides to electron-deficient olefins and its application to the synthesis of side-chain analogs of the hormone 1-alpha-25-dihydroxyvitamin D3".
Dijkstra Gerhardus D. H.
Halkes Sebastianus J.
Mascarenas Jose L.
Mourino Antonio
Sestelo Jose P.
Duphar International Research B.V.
O'Sullivan Peter
LandOfFree
Vitamin D compounds and method of preparing these compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vitamin D compounds and method of preparing these compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vitamin D compounds and method of preparing these compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2068860